HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The Heidelberg classification of renal cell tumours.

Abstract
This paper presents the conclusions of a workshop entitled 'Impact of Molecular Genetics on the Classification of Renal Cell Tumours', which was held in Heidelberg in October 1996. The focus on 'renal cell tumours' excludes any discussion of Wilms' tumour and its variants, or of tumours metastatic to the kidneys. The proposed classification subdivides renal cell tumours into benign and malignant parenchymal neoplasms and, where possible, limits each subcategory to the most commonly documented genetic abnormalities. Benign tumours are subclassified into metanephric adenoma and adenofibroma, papillary renal cell adenoma, and renal oncocytoma. Malignant tumours are subclassified into common or conventional renal cell carcinoma; papillary renal cell carcinoma; chromophobe renal cell carcinoma; collecting duct carcinoma, with medullary carcinoma of the kidney; and renal cell carcinoma, unclassified. This classification is based on current genetic knowledge, correlates with recognizable histological findings, and is applicable to routine diagnostic practice.
AuthorsG Kovacs, M Akhtar, B J Beckwith, P Bugert, C S Cooper, B Delahunt, J N Eble, S Fleming, B Ljungberg, L J Medeiros, H Moch, V E Reuter, E Ritz, G Roos, D Schmidt, J R Srigley, S Störkel, E van den Berg, B Zbar
JournalThe Journal of pathology (J Pathol) Vol. 183 Issue 2 Pg. 131-3 (Oct 1997) ISSN: 0022-3417 [Print] England
PMID9390023 (Publication Type: Consensus Development Conference, Editorial, Research Support, Non-U.S. Gov't, Review)
Topics
  • Adenoma (classification)
  • Carcinoma, Papillary (classification)
  • Carcinoma, Renal Cell (classification, genetics)
  • Humans
  • Kidney Neoplasms (classification, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: